Subtitle: The Prophylactic Hepatitis B Virus Vaccines Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Prophylactic Hepatitis B Virus Vaccines Market: Drivers and Challenges
The prophylactic hepatitis B virus vaccines market is expected to grow remarkably during the forecast period due to increasing prevalence and incidence of hepatitis B infection, increasing public awareness (Patient Education Programs), government initiatives for promotion and creating awareness about prophylactic hepatitis B vaccines. However, factors such as side effects of the vaccine, high costs incurred during research and development and macro-economic factors like stringent regulations can affect the market adversely.
Ever since 1982, vaccines were available for prevention of hepatitis B viral infections and currently more than 1 Bn doses of HBV vaccines have been distributed worldwide. The WHO recommends that all infants should receive the hepatitis B vaccine within 24 hours of birth. Thus, increase in the population base in APAC is expected to contribute significantly to the growth of global prophylactic hepatitis B virus vaccines market.
Prophylactic Hepatitis B Virus Vaccines Market: Regional Overview
Geographically, the global prophylactic hepatitis b virus vaccines market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global prophylactic hepatitis B virus vaccines market followed by APAC and Europe. According to WHO, globally more than 240 Mn people suffer from chronic hepatitis B viral infection and about 780,000 people die every year due to consequences related with HBV infection. Of these majority of people belong to developing nations of APAC, Latin America and Africa. The prevalence is considerably low in countries with high level of living standards such as the U.S., Canada, U.K., France, Germany, Italy and Spain.
Prophylactic Hepatitis B Virus Vaccines Market: Key Players
Some of the major players operating in the market for prophylactic hepatitis B virus vaccines are Merck & Co, Inc., Sanofi Pasteur, Novartis AG, Pfizer Inc., GlaxoSmithKline to name a few. Vaccine market is an oligopolistic market in which the major players such as GlaxoSmithKline, Merck & Co, Inc. and Sanofi Pasteur are using cost leadership and differentiating strategy. The strategy of the major companies in the global prophylactic hepatitis B virus vaccines market is to cut down the prices owing to the increased demand.
Browse Full Report summary and to request sample report and table of content@ http://www.persistencemarketresearch.com/market-research/prophylactic-hepatitis-b-virus-vaccines-market.asp
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353